Graham Parry
Förmögenhet: 1 $ per 2026-08-31
Förmögenhet: 1 $ per 2026-08-31
Dr. Graham Parry is a Chief Scientific Officer at Electra Therapeutics, Inc. Dr. Parry was previously employed as an Executive Vice President-Translational Sciences by Star Therapeutics, Inc., a Senior Vice President-Translational Sciences by Third Harmonic Bio, Inc., a Vice President-Technical Operations by True North Therapeutics, Inc., a Biology Director by Attenuon, LLC, and a Principal by Motility, Inc. He received his undergraduate degree from Brunel University London and a doctorate degree from the University of London.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-21 | 85 504 ( 0,22 % ) | 1 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-12-01 |
| Företag | Position | Slut |
|---|---|---|
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Företagsledare/Principal | 2023-12-01 |
| THIRD HARMONIC BIO, INC. | Företagsledare/Principal | 2022-12-01 |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Teknisk/Vetenskaplig/F&U Direktör | 2017-01-01 |
Motility, Inc. | Företagsledare/Principal | - |
Attenuon, LLC
Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Brunel University
Brunel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attenuon, LLC
Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Motility, Inc. | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological and cancer diseases | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån